Opinion

Hormones after cancer: Are they safe?
- Author:
- Emma C. Rossi, MD
Publish date: April 20, 2022
Opinion

The medical management of early-stage endometrial cancer: When surgery isn’t possible, or desired
- Author:
- Emma C. Rossi, MD
Publish date: March 9, 2022
Opinion

Optimizing ‘optimal’ in ovarian cancer cytoreduction
- Author:
- Emma C. Rossi, MD
Publish date: January 26, 2022
Opinion

Evaluating phantom hCG and low-level hCG elevations in the nonpregnant patient
- Author:
- Emma C. Rossi, MD
Publish date: October 28, 2021
Opinion

Management of advanced endometrial cancer
- Author:
- Emma C. Rossi, MD
Publish date: September 23, 2021
Opinion

Recommendations from a gynecologic oncologist to a general ob.gyn., part 2
- Author:
- Emma C. Rossi, MD
Publish date: August 24, 2021
Opinion

Decision making regarding LEEP versus cone biopsy for excision of cervical dysplasia
- Author:
- Emma C. Rossi, MD
Publish date: May 25, 2021
Opinion

Endometriosis-associated ovarian cancer
- Author:
- Emma C. Rossi, MD
Publish date: February 23, 2021
Opinion

Intraoperative rupture of ovarian cancer: Does it worsen outcomes?
- Author:
- Emma C. Rossi, MD
Publish date: January 27, 2021
Opinion

Are uterine manipulators safe for gynecologic cancer surgery?
- Author:
- Emma C. Rossi, MD
Publish date: October 28, 2020
Opinion

Molecular developments in treatment of UPSC
- Author:
- Emma C. Rossi, MD
Publish date: September 1, 2020
Opinion

Treating VIN while preventing recurrence
- Author:
- Emma C. Rossi, MD
Publish date: July 28, 2020
Opinion

Disparity in endometrial cancer outcomes: What can we do?
- Author:
- Emma C. Rossi, MD
Publish date: November 1, 2019
Opinion

Ovarian cancer and perineal talc exposure: An epidemiologic dilemma
- Author:
- Emma C. Rossi, MD
Publish date: August 26, 2019
Opinion

Discuss compounded bioidentical hormones and cancer risk
- Author:
- Emma C. Rossi, MD
Publish date: April 30, 2019